Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell BioNano Genomics Inc (BNGO) – BioNano Genomics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bionano Genomics (BNGO) trades at $1.21, showing no change in the last session. The stock exhibits a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company continues to report losses with a net income margin of -92.59% for 2025, though recent quarterly earnings have consistently beaten analyst expectations. Revenue for 2024 was $30.78 million with a gross profit margin of 46.25%. Recent news highlights positive study publications demonstrating the utility of its optical genome mapping technology.
The outlook presents a high-risk, high-potential scenario. Analyst consensus is bullish with 4 buy ratings and no sell ratings. The primary opportunity lies in the company's innovative OGM technology gaining clinical and research adoption, which could drive future revenue growth. Key risks include persistent cash burn, negative profitability metrics, and execution challenges in scaling the business amid competitive pressures.
Read full analysis

Key Stats

  • Market Cap
    $13.42M
  • Sector
    Health
  • 3M Drawdown
    -29.22%
  • Enterprise Value
    $1.07M
  • Dividend Yield
    -
  • Typical Hold Time
    39 days
$1.21
52W Low: $1.09
12 Feb 2026
52W High: $4.92
10 Sep 2025

BioNano Genomics Inc (BNGO) is currently valued at a market capitalization of $13.42M, with an enterprise value of $1.07M. Over the past 52 weeks, BioNano Genomics Inc has traded between a low of $1.09 and a high of $4.92, highlighting its annual price range. Over the past three months, BioNano Genomics Inc has recorded a drawdown of -29.22%, reflecting recent price volatility. On average, investors hold BioNano Genomics Inc for approximately 39 days, indicating typical investor behavior on the platform.

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.


Technical Indicators
|
|
|
Overall Summary
Bearish (12)Neutral (1)Bullish (14)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $13.42M
  • Sector
    Health
  • 3M Drawdown
    -29.22%
  • Enterprise Value
    $1.07M
  • Dividend Yield
    -
  • Typical Hold Time
    39 days
$1.21
52W Low: $1.09
12 Feb 2026
52W High: $4.92
10 Sep 2025

BioNano Genomics Inc (BNGO) is currently valued at a market capitalization of $13.42M, with an enterprise value of $1.07M. Over the past 52 weeks, BioNano Genomics Inc has traded between a low of $1.09 and a high of $4.92, highlighting its annual price range. Over the past three months, BioNano Genomics Inc has recorded a drawdown of -29.22%, reflecting recent price volatility. On average, investors hold BioNano Genomics Inc for approximately 39 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!